ETNB - 89bio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.17
DETAILS
HIGH:
$25.00
LOW:
$12.00
MEDIAN:
$14.50
CONSENSUS:
$17.17
UPSIDE:
15.70%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 13.19 |
| Quick Ratio | 13.19 |
| Solvency Ratio | -4.879 |
| Cash Ratio | 3.49 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-2.23
Peers avg: 2.1
|
| PEG Ratio | -0.03 |
| Forward PEG | -0.03 |
| Price/Book | 2.04 |
| Price/Sales | 0.00 |
| Price/FCF | -2.23 |
| Price/Op Cash Flow | -2.23 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0784 |
| Debt/Equity | 0.0937 |
| Debt/Capital | 0.0857 |
| Long-Term Debt/Capital | 0.0819 |
| Financial Leverage | 1.19 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -10.181 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -101.76 |
| Interest Coverage | -101.5727 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -9.80 |
| Capital Expenditure Coverage | -24521.53 |
| Dividend + Capital Expenditure Coverage | -24521.53 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -3.506 |
| Debt/Share | 0.3947 |
| Cash/Share | 4.20 |
| Book Value/Share | 3.83 |
| Tangible BV/Share | 3.83 |
| Equity/Share | 3.83 |
| Operating Cash Flow/Share | -3.513 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -3.513 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.002 |
| Earnings Before Tax/EBIT | 0.953 |
| Price/Fair Value | 2.04 |
| Debt/Market Cap | 0.0436 |
| Effective Tax Rate | -0.2% |
| Enterprise Value Multiple | -1.90 |